SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950142-21-003244
Filing Date
2021-10-20
Accepted
2021-10-20 09:00:40
Documents
18
Period of Report
2021-10-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh210193502_8k.htm   iXBRL 8-K 33906
2 EXHIBIT 10.1 eh210193502_ex1001.htm EX-10.1 52567
3 EXHIBIT 10.2 eh210193502_ex1002.htm EX-10.2 86001
4 EXHIBIT 10.3 eh210193502_ex1003.htm EX-10.3 49280
5 EXHIBIT 99.1 eh210193502_ex9901.htm EX-99.1 10850
9 GRAPHIC logo.jpg GRAPHIC 13256
10 GRAPHIC footer_logo.jpg GRAPHIC 12137
  Complete submission text file 0000950142-21-003244.txt   492777

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vtvt-20211019.xsd EX-101.SCH 3046
7 XBRL LABEL FILE vtvt-20211019_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE vtvt-20211019_pre.xml EX-101.PRE 22373
11 EXTRACTED XBRL INSTANCE DOCUMENT eh210193502_8k_htm.xml XML 3610
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 211332873
SIC: 2834 Pharmaceutical Preparations